Free Trial
NASDAQ:SLGC

Standard BioTools (SLGC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.93
$2.31
50-Day Range
$2.10
$2.83
52-Week Range
$1.73
$3.79
Volume
33.91 million shs
Average Volume
10.83 million shs
Market Capitalization
$394.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.43
SLGC stock logo

About Standard BioTools Stock (NASDAQ:SLGC)

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for its cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various biological samples for protein biomarker signatures, which are utilized in drug discovery and development. Its SomaScan's biomarker discoveries use in diagnostic applications for various diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company also provides SomaSignal, a laboratory-developed test. It serves pharmaceutical and biotechnology companies, and academic and government research institutions. The company has a collaboration agreement with Illumina Cambridge, Ltd for the development of co-branded NGS-based proteomic distributable kits. The company was founded in 1999 and is headquartered in Boulder, Colorado.

SLGC Stock News Headlines

Standard BioTools Inc LAB
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
LAB May 2024 2.500 call
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
See More Headlines
Receive SLGC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Standard BioTools and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
7/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:SLGC
Fax
N/A
Employees
451
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$2.43
High Stock Price Target
$2.50
Low Stock Price Target
$2.30
Potential Upside/Downside
+15.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-109,160,000.00
Net Margins
-159.54%
Pretax Margin
-159.08%

Debt

Sales & Book Value

Annual Sales
$97.67 million
Book Value
$3.00 per share

Miscellaneous

Free Float
160,049,000
Market Cap
$394.95 million
Optionable
Optionable
Beta
1.64
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Stephen A. Williams BS (Age 64)
    MB, Ph.D., Chief Medical Officer
    Comp: $648.03k
  • Mr. Adam Taich (Age 49)
    Interim CEO
  • Mr. Pi Zheng (Age 51)
    Interim Chief Accounting Officer
  • Dr. Jason Cleveland Ph.D.
    Chief Technology Officer
  • Dr. Nebojsa Janjic Ph.D. (Age 63)
    Chief Science Officer
  • Mr. Ruben Gutierrez J.D. (Age 49)
    General Counsel
  • Ms. Alison Marie Roelke (Age 49)
    Chief People Officer
  • Dr. Shane Bowen Ph.D.
    Chief Research & Development Officer

This page (NASDAQ:SLGC) was last updated on 7/14/2024 by MarketBeat.com Staff

From Our Partners